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Common themes are emerging in the molecular mecha-
nisms of long non-coding RNA-mediated gene repres-
sion. Long non-coding RNAs (lncRNAs) participate in
targeted gene silencing through chromatin remodelling,
nuclear reorganisation, formation of a silencing domain
and precise control over the entry of genes into silent
compartments. The similarities suggest that these are
fundamental processes of transcription regulation gov-
erned by lncRNAs. These ﬁndings have paved the way
for analogous investigations on other lncRNAs and chro-
matin remodelling enzymes. Here we discuss these com-
mon mechanisms and provide our view on other
molecules that warrant similar investigations. We also
present our concepts on the possible mechanisms that
may facilitate the exit of genes from the silencing
domains and their potential therapeutic applications.
Finally, we point to future areas of research and put for-
ward our recommendations for improvements in resour-
ces and applications of existing technologies towards
targeted outcomes in this active area of research.
Keywords: .airn/Kcnq1ot1; enhancers; epigenetic modifications; non-
coding RNA; Xist/HOTAIR; imprinting
Introduction
Long non-coding RNAs (lncRNAs) are molecules often longer
than 2 kb in length with a coding potential of less than 100
amino acids [1–3]. The number of lncRNAs exceeds that of
protein coding genes [4–6] and their discovery has revolu-
tionised the ﬁeld of molecular biology.
Since their sequence provides no obvious clues regarding
their function and the fact that they are poorly conserved
across species, ncRNAs were viewed as non-functional and
their presence and signiﬁcance is still being debated [7–9].
However, as new studies identify the functions of individual
ncRNAs, it is now apparent that many ncRNAs are the key
regulators of transcriptional and translational output and
therefore of cell fate and function [10–12]. While most
mRNAs are exported to the cytoplasm for translation, many
lncRNAs are now known to be retained in various sub-nuclear
compartments [6, 13–15] suggesting that such RNAs may have
a potential function in the compartment where they are
localised.
Several nuclear lncRNAs have been studied in detail and
investigations into the molecular functions of lncRNAs reveal
more unexpected similarities in molecular functions than
previously anticipated. Here, we will focus on some examples
that provide important paradigms for gene regulation by
lncRNAs through interaction with chromatin remodelling
complexes. We believe that we have discovered only the tip
of the iceberg of a hitherto unknown network of nuclear non-
coding RNA/chromatin interaction.
Studies on four lncRNAs (Kcnq1ot1, Airn, Xist and HOTAIR)
investigated individually by independent laboratories reveal
that their function is to regulate transcription of multiple
target genes through epigenetic modiﬁcations. These investi-
gations have established fundamental principles of lncRNA
function with broad implications. On the mouse X-chromo-
some, expression of lncRNA X-inactive speciﬁc transcript
(Xist) from the designated inactive X-chromosome is essential
for the silencing of the inactive X-chromosome [16–19]. On
the Insulin like growth factor 2 receptor (Igf2r) imprinted
cluster, located on mouse chromosome 17, the expression of
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spaternal-speciﬁc non-coding transcript antisense Igf2r RNA
non-coding (Airn,108 kb),is requiredforthesilencing of three
genes on the paternal allele. These genes are spread over a
large genomic region spanning 400 kb [20]. On mouse
chromosome 7, the potassium voltage-gated channel subfam-
ily Q member 1 (Kcnq1) imprinted cluster, spread over a 1 Mb
genomic region in embryos, contains multiple genes and is
silenced on the paternal allele by the un-spliced lncRNA Kcnq1
overlapping transcript 1 (Kcnq1ot1, 91 kb) in cis [21, 22]. Some
genes on the Homeobox D (HOXD) cluster, located over a
40 kb genomic region on human chromosome 2, are silenced
by lncRNA HOTAIR, which originates from the HOXC cluster
on chromosome 12 [23]. The elucidation of the molecular
mechanisms of such long-range regulation reveals at least
three common themes in the silencing process (Table 1).
Silencing mediated bylncRNAs isimposed
via recruitment of chromatin remodelling
complexes
TheinvolvementofRNAsinepigeneticsilencingwasproposed
by various investigators [24, 25] based on the observation that
while many enzymatic members of the chromatin remodelling
complexesdidnothaveDNAbindingdomains,theypossessed
RNA binding domains. Molecular investigations revealed
the association between lncRNAs such as Kcnq1ot1, Airn,
Xist, HOTAIR and chromatin remodelling complexes such
as Polycomb repressive complexes 1 and 2, (PRC1 and PRC2)
[22, 23, 26–32] which mediate mono-ubiquitinylation of Lysine
119 of Histone 2A (H2AK119ub)[33] and di- and tri-methylation
of Histone 3 lysine 27 (H3K27me2 and H3K27me3)[34, 35],
respectively; Lysine Speciﬁc Demethylase 1 (LSD1)/CoREST
which demethylates mono- and di-methylated Histone 3 at
Lysine4(H3K4)[36]andG9ahistonemethyltransferasewhich
catalyses Histone 3 Lysine 9 di- and tri-methylation (H3K9me2
and H3K9me3) [37, 38].
At the Kcnq1 imprinted locus, Kcnq1ot1 lncRNA interacts
with histone methyltransferase G9a and members of the PRC2
complex [22]. In addition, Terranova et al. reported close
proximity between Kcnq1ot1 lncRNA and members of PRC2
and PRC1 complex [28]. At the Igf2r imprinted locus, Airn also
associates with G9a [27]. The imprinted genes in the Igf2r and
Kcnq1 clusters show repressive histone marks of K3K9me3 and
H3K27me3 most likely induced by G9a and PRC2-remodelling
complexes, respectively [22, 27]. It should be noted that these
studies were performed in extra embryonic placental tissue in
mouseandthemechanismsofimprintinginembryonictissues
may be different. On the X-chromosome, Xist lncRNA interacts
with Ezh2 and Suz12 components of the PRC2 complex via a
repeat A region (RepA) and the recruitment of PRC2 to the
inactive X-chromosome induces the repressive epigenetic
mark of H3K27me3 [31]. At the HOXD locus, HOTAIR also
recruits PRC2 complex to induce silencing of speciﬁc genes
[23]. It is noteworthy that at some of the loci mentioned above,
the target genes fail to be silenced in the absence of the
lncRNA [20, 23, 31, 39] thus implying that lncRNAs are essen-
tial for steering chromatin remodelling complexes to distinct
target sites in order to induce silencing. Since these complexes
interact with multiple lncRNAs, it appears that association
with lncRNAs deﬁnes their target speciﬁcity. For example the
repressive complex G9a, in concert with lncRNA Airn, targets
the Igf2r imprinted locus, while in association with Kcnq1ot1,
G9a represses genes in the Kcnq1 locus [22, 27]. Similarly PRC2
in association with HOTAIR, targets the HOXD locus [23]; with
Kcnq1ot1 it targets the Kcnq1 cluster [22], and while associated
with RepA/Xist, it modiﬁes histones on the X-chromosome
[31]. Thus each protein complex is capable of being directed
by multiple lncRNAs (Fig. 1 A–D). However, it is not clear if
members of chromatin remodelling protein complexes have
distinct domains for binding with speciﬁc ncRNAs or whether
they bind in general to ncRNA molecules presenting certain
secondary structures as seen in Xist [31, 40]. Indeed, it has
recently been reported that short RNAs (50–200 nt), tran-
scribed from repressed loci by stalled RNA polymerase II,
interact with the PRC2 complex through their stem loop
secondary structure and mediate gene repression through
epigenetic modiﬁcation [41]. It is not known whether the other
ncRNAs such as Promoter associated short and long RNAs
(PASRs, and PALRs) and promoter upstream transcripts
(PROMPTs) generated around promoters as well as the vast
numbers of small RNAs now known to be retained in the
nucleus [6, 15, 42–44] possess distinct secondary structures
and participate in local epigenetic regulation through inter-
action with chromatin remodelling complexes.
Interestingly, some lncRNAs also appear to interact with
more than one chromatin-modifying complex. For example
HOTAIR is known to interact with both PRC2 and LSD1/
Table 1. List of investigated long non-coding RNAs and their protein partners
lncRNA
Size
(kb) Spliced Cover Regulated genes Escaped genes
Chromatin
remodelling
complex Ref.
Airn 108 Yes Yes Multiple genes, in cis clusters Yes, development specific
escape
G9a [20, 27]
Kcnq1ot1 94 No Yes Multiple genes in cis clusters Yes, tissue specific escape G9a [22, 50]
PRC2
PRC1
Xist 17 Yes Yes Multiple genes in cis clusters on
X chromosome
Yes, development specific
escape
PRC2 [31, 67–69]
HOTAIR 2 Yes Not
known
Multiple genes in trans at HOXD
locus, individual targets all over
the genome
N/A PRC2 [23, 29]
LSD1
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sCoREST/REST complexes [29] and Kcnq1ot1 interacts with
G9a as well as the PRC2 complex [22, 28, 30]. Recent reports
identify ANRIL (antisense non-coding RNA in the INK4 locus)
as another candidate lncRNA which interacts with more than
one chromatin remodelling complex to induce silencing in cis
[45, 46]. ANRIL (3.8 kb) originates close to
the INK4A gene on chromosome 9 in
humans and interacts with the CBX7 com-
ponent of the PRC1 complex to induce
silencing of the INK4A and INK4B loci
[46] and with SUZ12 component of
the PRC2 complex to mediate epigenetic
silencing of the p15
INK4B gene [45]. Thus
the interaction of a single ncRNA with
multiple chromatin modifying complexes
to target speciﬁc genes may be a wide-
spread phenomenon.
Indeed, in a high throughput RIP-Chip
analysis, Khalil et al. found that 40% of
long intergenic ncRNAs (lincRNAs) associ-
ated with the CoREST complex were also
associated with the PRC2 complex, indicat-
ing that lincRNAs can have shared and
independent targets [26]. Genome wide
ChIP-Chip analysis of human promoters
reveals 4,740 and 2,116 gene promoters
occupied by PRC2 and LSD1, respectively,
while 721 promoters are occupied by both
complexes, suggesting shared and individ-
ual targets of each complex [29]. It is likely
that repression at shared targets is medi-
ated by ncRNAs capable of binding more
than two complexes as seen with HOTAIR
[29]. Thus it is now apparent that target
speciﬁcity of lncRNAs can also be altered
depending on the interacting chromatin
modifying complex. These multiple inter-
actions between chromatin complexes and
lncRNAs may be sequence dependent as in
the case of HOTAIR which has distinct
domains for interaction with PRC2 and
LSD1 [29]. However, the target distinction
of the lncRNA-chromatin remodelling
complexes is most likely mediated by con-
formational changes induced by these
interactions (Fig. 1). It should be noted that
while the ncRNAS mentioned above are
certainly required for the initiation of
silencing at their respective targets, it is
not yet clear if like Xist, they are dispen-
sable for the maintenance of silent epige-
netic state at their target loci.
Additional mechanisms of ncRNA
mediated silencing may exist in a gene or
tissue speciﬁc manner. Certainly, Airn uti-
lises gene speciﬁc silencing mechanisms
even within the placenta, the Slc22a3 gene
is silenced through recruitment of G9a,
however silencing of the neighbouring
Igf2r gene does not require G9a since its
imprinted status is not affected in G9a KO mice [27]. In mouse
ES cells, the Igf2r gene is persistently expressed at low levels
from the paternal imprinted allele despite DNA methylation at
its promoter [47], indicating that Airn transcription itself may
interfere with transcription initiation at Igf2r [48, 49]. At the
Figure 1. Complexity in lncRNA-chromatin modifying complex interactions. Chromatin
remodelling complexes are capable of interacting with multiple lncRNAs. Similarly,
lncRNAs may interact with more than one protein complex. A to D: Protein lncRNA inter-
actions may result in conformational changes, which may help distinguish target speci-
ﬁcity. E: Chromatin remodelling complexes F: Hypothetical nucleus depicting lncRNA–
protein complexes and their silencing compartments. Xist domain is shown at the nuclear
periphery with inactive X chromatin. Airn and Kcnq1ot1 are shown to silence speciﬁc
genes on their respective imprinted loci while HOTAIR is seen to target loci genome wide
in concert with different protein complexes. Note that mouse Hotair does not participate
in silencing the HoxD cluster and is not reported to interact with chromatin remodelling
complexes [55]. Human HOTAIR is depicted in this schema.
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sKcnq1locus,ubiquitouslyimprintedgenes(genesimprintedin
placenta, embryo and adult tissues) are silenced in the pla-
centa and liver by recruitment of Dnmt1 by Kcnq1ot1 [50]. The
observation of imprinting and X inactivation phenomena,
despite the poor conservation of ncRNAs such as Airn in
opossum and dog [51, 52] and Xist in marsupials [53, 54]
and the presence of a dysfunctional, poorly conserved
Hotair in mouse [55], suggests the existence of compensatory
layers of gene regulation in such species. It is likely that other
modes of silencing may also emerge as common mechanisms
for ncRNA-mediated silencing. Alternatively, the functional
module of the lncRNAs in such species may be much shorter
and dependent on secondary structure rather than length or
primary sequence.
The promoters of genes silenced by
lncRNAs are covered with lncRNAs
A physical association between lncRNAs and the chromatin of
their target loci is emerging as a common theme for very long
ncRNAs that silence genes in clusters. Xist was ﬁrst shown by
RNA-FISH studies to coat the chromatin at the inactive X
chromosome in a non-uniform manner, where euchromatic
regions on the inactive X remained devoid of Xist coating in
the initial stages of X-chromosome inactivation [56–58]. The
physical association of Xist with chromatin was further con-
ﬁrmed by immunoprecipitation with antibodies against
macroH2A1, a histone H2A variant enriched on the inactive
X chromosome [59] (reviewed in [60]). On the Kcnq1 locus,
RNA-DNA-FISH studies reveal that Kcnq1ot1 also associates
with imprinted genes on the Kcnq1 imprinted chromatin
region [22, 61, 62] and at the Igf2r locus. Nagano et al. dem-
onstrated through RNA-DNA-FISH a cloud of ‘Airn’ over the
imprinted Slc22a3 at E11.5 [27]. Such a ncRNA-cloud has not
yet been reported for HOTAIR, which mediates silencing in
trans and is only 2 kb long. Current data are insufﬁcient to
conclude whether this covering of targets is the exclusive
property of long ncRNAs acting in cis over clustered targets.
The coating of lncRNA over targeted genomic loci is postu-
lated to create a ‘silent nuclear compartment’ resulting in the
recruitment of chromatin remodelling complexes to maintain
silent chromatin marks and restrict access to the transcrip-
tional machinery [63]. At the sub-nuclear level, such silent
compartments created by Xist and Kcnq1ot1 cover have been
reported to localise to the perinucleolar region [22, 64, 65]
suggesting that lncRNAs may induce changes in the spatial
organisation of chromatin in the nucleus. It is notable that the
lncRNAs involved in the formation of these silent domains are
cis acting, particularly long (over 10 kb) and known to silence
genes spread over large genomic loci on single chromosomes.
It is not known if the many small RNAs retained in the nucleus
participate in the formation of such clouds, since it is difﬁcult
to visualise small RNAs with current techniques such as FISH.
Chow et al. recently reported the presence of small siRNAs
arising from the young LINE1 elements in the Huwe-1 gene,
which facilitate its silencing by inclusion into the Xist domain
[66]. Kanhere et al. reported sRNAs arising from PRC2 target
genes that participate in the recruitment of PRC2 to their
promoters [41]. It will be of interest to investigate if these
short RNAs remain in the vicinity of their target loci and
participate in the formation of a cover.
Silenced genes enter while active genes
remain outside the lncRNA silencing
compartment
ThelocationofgenesunderthecoveroflncRNAsappearstobe
dynamic. Detailed analyses reveal that the genes that undergo
X-inactivation gradually relocate deep inside the Xist-covered
silent compartment as they are silenced [63]. Genes that
escape X-inactivation remain outside this silent domain
[63]. It was recently shown that inclusion of genes within
the Xist silencing compartment is dependent on the density
and proximity of young full length long interspersed nuclear
elements (LINEs) to the genes [66]. However, the evidence
from genes such as Jarid1c (Kdm5c/Smcx), Shroom2 and Mid1,
which undergo tissue or development stage speciﬁc inacti-
vation[67–69], suggeststhatinadditiontotheabundanceand
proximity of LINEs, other tissue/development-speciﬁc factors
may also play a role in facilitating inclusion into the silencing
compartment. Jarid1c is a LINE poor gene [66], which initially
undergoes X-inactivation but is activated at later stages of
development [67]. Jarid1c is expressed at equal levels in males
and femalesin neonatalbrains andadult liver [70]but escapes
X-inactivation in adult female brains [70]. RNA-DNA-FISH
studies reveal that Jarid1c remains at the inner edge of the
Xist silent compartment in cells where it is inactive and it is
located outside the Xist compartment in cells where it is active
[63]. Another gene Shroom2, undergoes X-inactivation and
displays PRC2-mediated H3K27me3 mark of repressive chro-
matin in a tissue speciﬁc manner; while Mid1 gene shows
H3K27me3 enrichment in female embryos but not in adult
liver, indicating that it undergoes X-inactivation in embryonic
tissues and later escapes X-inactivation [69]. Although RNA-
DNA-FISH data for Mid1 and Shroom2 are not available, it is
plausible that these genes are also located inside the Xist
silencing compartment when they undergo X-inactivation.
To escape inactivation Mid1 and Shroom2 would have to exit
the silencing compartment, since the transcription machinery
is located outside this compartment.
The exit of genes from lncRNA silencing domains is also
seen at the imprinted loci. The Slc22a3 gene is imprinted in
embryos at E11.5 but shows biallelic expression at E15.5 [27].
Using RNA-DNA-FISH techniques, Nagano et al. demonstrated
Slc22a3 inside the silencing compartment under cover of Airn
at E11.5 when it is imprinted and a reduction in Slc22a3 loci
covered by Airn at E15.5 after escape from imprinting [27]. The
interaction between Airn and the Slc22a3 promoter demon-
strated by RNA TRAP experiments at E11.5 was reduced at
E15.5 [27]. On the Kcnq1 cluster, genes are differentially
regulated in placenta and embryos at E12.5 and studies of
the lncRNA cover index over such genes suggests that only
silenced genes remain inside the inactivation domain [61].
Interestingly, the imprinted loci are not particularly abundant
in LINEs [71] suggesting that factors other than LINEs regulate
the inclusion of genes in the silencing compartment at the
imprinted loci. The fact that on the X-chromosome, as well
as the imprinted loci, genes can escape from the silencing
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despite the presence of the perpetrating lncRNA and repres-
sive chromatin complexes in the vicinity, also suggests an
additional layer of regulatory control that governs exit from
the silencing compartment. Furthermore, tissue/development
stage-speciﬁc silencing of X-linked and imprinted genes
[67, 69, 70, 72] also argues against genomic features as key
regulators of entry into silencing domains and suggests that at
certain loci inclusion into lncRNA silencing compartment may
be regulated by other factors responsive to development stage
ortissuespeciﬁcmolecularsignals.Intriguingly,theabundant
expression and retrotransposition of LINE-1 in neuronal
precursor cells is postulated to create gene disruption and
diversity in the genome [73].
ItwillbeofinteresttoinvestigateifsuchLINEsalsoplayan
active role in gene silencing by facilitating the inﬂuence of
lncRNAs.
Possible role for enhancers in escaping
epigenetic regulation mediated by
lncRNAs
It is now apparent that genes once silenced by inclusion into
the silent domains of the lncRNAs are capable of reactivation
in a tissue or development stage speciﬁc manner.
This reactivation most likely requires the genes to escape
from the silent compartment. What regulates the exit of genes
from the silencing domains created by lncRNAs? For such
regulation to be effective, the controlling mechanism must
remain outside the inﬂuence of the silencing compartment
mediatedbylncRNAsandbeabletorespondtodevelopmental
cues. Genomic regions called enhancers meet both require-
ments and are likely candidates for such regulation.
Enhancers are DNA elements which provide binding sites
for sequence speciﬁc transcription factors and induce tran-
scription by facilitating the recruitment of RNA pol II to pro-
moters (reviewed in [74]). FISH and 3C studies have shown
that enhancers activate transcription in cis and in trans and
that transcription activation by enhancers requires physical
contact with the promoters via chromatin looping [75]. It is
now known that distal elements bound by p300 with a chro-
matin signature of high H3K4me1 and H3K27ac and low
H3K4me3 marks enhancers while core promoters are nucleo-
some free regions ﬂanked by high H3K4me3 and bound by
RNA polymerase II [76, 77]. About 25% of enhancers are also
bound by RNA polymerase II [78] and it was recently reported
that a fraction of extra-genic and intra-genic enhancers are
actively transcribed from the H3K4me1 domain, giving rise to
non-polyadenylated bidirectional transcripts called enhancer
RNAs (eRNAs) [78, 79].
Although the function of eRNAs is as yet unclear, their
expression levels are reportedly concordant with the expres-
sion levels of their target promoter transcripts [78] and their
induction is reported to be a precise indication of the physical
contact between enhancers and their target promoters [80].
Enhancers show developmental and activity dependent
plasticity and tissue speciﬁcity [78, 81–83] indicating that they
are responsive to cellular signals. Due to their physical
distance from the target promoters, upon silencing of target
genes via inclusion into ncRNA silencing compartments, the
distal enhancers are likely to remain outside the repressive
domains. Such regulatory genomic regions may be involved in
mediating the escape from lncRNA mediated silencing. In
particular their ability to contact promoter regions through
looping of chromatin may play a role in rescuing genes out of
the silent domains (Fig. 2).
An area of future research could be to investigate if genes
exit the lncRNA covered silent compartment with the help of
eRNAs. The fact that epigenetic modiﬁcation is precisely exe-
cuted at speciﬁc promoters implies that a mechanism exists
within cells to facilitate recognition of speciﬁc promoters.
Recent evidence indicates that double stranded short syn-
thetic RNAs targeted at promoter regions (agRNAs) can medi-
ate silencing as well as activation of the targeted promoters
[84–87], indicating that sRNAs can recognise genomic pro-
moters of their origin. agRNAs were shown to form a complex
with AGO protein and a locally arising antisense ncRNA at the
Progesterone receptor (PR) locus [88], suggesting that pro-
moter speciﬁc RNAs may require other ncRNA mediators to
execute their function. Non coding RNAs have been shown to
be transcribed from active [1, 6, 15, 44, 89] as well as repressed
promoters [41]. It is probable that some of these promoter
speciﬁc RNAs utilise sense or antisense eRNAs as the ncRNA
mediators to bring into physical proximity, silenced target
genes and their enhancers via chromatin looping. These
eRNA complexes may then compete with lncRNAs for the
chromatin repressor complexes and facilitate reactivation of
silenced genes, thus mediating exit from the repressive com-
partment. Alternatively, eRNAs may interact with chromatin
activating complexes, and upon close proximity with target
genes, induce activation through epigenetic remodelling thus
mediating exit from the silencing domain (Fig. 2).
Therapeutic applications of manipulating
lncRNA mediated silencing
From the discussion above it is apparent that lncRNA medi-
ated repression of genes is an intricate process involving
chromatin remodelling enzymes and spatial reorganisation.
The involvement of multiple factors suggests that the process
is open to experimental manipulation at multiple levels. To be
inactivated by Xist, genes on the X-chromosome require an
abundanceofLINEsinthegenomicregionandtranscriptionof
young LINE-1 from their vicinity [66]. In mammalian genomes,
both full-length and truncated LINEs can be transcribed [90].
It is not clear what marks the imprinted genes must carry to
distinguish them from non-imprinted genes within thecluster.
Nevertheless the silencing and escape of genes appear to be
tightly regulated and the nature of such regulation warrants
investigation as it may have therapeutic applications in some
disorders such as Rett Syndrome.
Rett Syndrome is an X-linked dominant neuro-develop-
mental disorder where mutations in the MECP2 gene cause
arrest of neurodevelopment in girls [91]. Girls with Rett syn-
drome possess one normal and one mutant copy of the MECP2
gene. Since MECP2 gene undergoes X-inactivation [63], in Rett
patients, the normal copy of MECP2 gene is active only in 50%
of cells while the other 50% cells express the mutant gene,
A. Saxena and P. Carninci Prospects & Overviews....
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seen in Rett Syndrome are presumably dependent on the X-
inactivation status of the patient [92, 93]. However, recent
studies also implicate other factors [94, 95]. The MECP2 locus
on the X-chromosome is drawn inside the Xist silencing com-
partment at day 4 after differentiation [63]. Activation of the
inactive non-mutant MECP2 gene has long been proposed as a
therapeutic avenue for Rett Syndrome [96]. The Mecp2 KO
male mice display striking phenotypic similarities to female
patients with MECP2 mutations [97].
Recently, Guy et al. reported a surprising reversal of the
Rett phenotype seen in an experimental mouse model of Rett
Syndrome by reactivation of the Mecp2 gene in a transgenic
mutant mouse. This provided the proof of principle that reac-
tivation of the normal copy of Mecp2 may provide therapeutic
beneﬁts in patients with loss of function MECP2 mutations
[98]. Thus a strategy of preventing the
inclusion of MECP2 in the silencing domain
at early stages of differentiation or enforc-
ing the exit of MECP2 gene from the XIST
silencing domain in differentiated cells
may have therapeutic applications.
It will be interesting to investigate if a
combined experimental approach of tar-
geted down regulation of allele speciﬁc
MECP2 related LINE elements and allele
speciﬁc over expression of MECP2 enhancer
eRNAs prevents inclusion into the silencing
compartmentandfacilitatesactivationofthe
MECP2 gene. Itis noteworthy that the MeCP2
protein is known to repress LINE-1 transcription [99–101] and
LINE-1 expression and retrotransposition is reported to be
signiﬁcantly higher in the adult Mecp2 KO mouse brain as seen
with genomic DNA and RNA analysis [100, 101].
In addition to Rett syndrome, manipulation of lncRNA
mediatedsilencingmayalsobebeneﬁcialinpreventingcancer
progression, recurrence and metastasis. Gupta et al. recently
reported that HOTAIR was over expressed up to 2,000-fold in
metastatic breast tumours [102]. They demonstrated a com-
bined role of HOTAIR and PRC2 complex in breast cancer
invasiveness via overexpression and knock down of
HOTAIR and PRC2 components through in vitro and in vivo
studies [102]. This study indicates that HOTAIR and PRC2
complex speciﬁcally act through silencing of metastasis
suppressor genes and alteration of the epigenetic program
of breast cancer cells to promote cancer progression and
Figure 2. Schematic representation of lncRNA mediated silencing and proposed mech-
anism for escape. A: Hypothetical genomic locus with three genes (as labelled) regulated
by a long non-coding RNA (blue) and a chromatin repressive enzyme complex (blue ovals)
is shown. A distal enhancer for Gene B is represented in magenta. B: At the appropriate
stage the lncRNA accumulates over the locus to form an lncRNA cloud. The cloud covers
the genes and compacts chromatin via chromatin remodelling complexes. C: Proposed
model for reactivation of silenced genes. A single gene is shown to escape silencing
through exiting the silencing domain by looping out of the repressive compartment and
physical contact with the distal enhancer. The chromatin looping may be mediated by
other ncRNAs arising from the gene itself (green) in concert with eRNAs (magenta). We
propose that enhancers may initiate the reactivation process through eRNAs via recruit-
ment of chromatin activating complexes (orange spheres) or through competition for
repressive complexes at the locus (not shown).
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smetastasis. Thus selective activation of key HOTAIR targets,
through agRNAs for example, may be beneﬁcial in preventing
invasiveness of tumours. In addition, recent studies indicate
that lncRNAs, which are highly expressed in solid tumours,
may be involved in cancer progression and metastasis
via other mechanisms. The Metastasis Associated Lung
Adenocarcinoma Transcript-1 (MALAT-1 aka NEAT-2)i s
sequestered in nuclear speckles and is believed to alter the
transcription program of cells through alternate splicing of
target genes [103]. Identifying other mechanisms of ncRNA
function may outline unforeseen strategies for cancer therapy.
Future studies
To unravel the molecules involved in epigenetic regulation by
lncRNAs, it is important to ﬁrst identify genes regulated by
lncRNAs. Global investigation of chromatin-RNA interactions
at different developmental stages is essential. Combined
sequencing of RNA and DNA molecules in close proximity
on a genomic scale will aid the discovery of chromatin-RNA
associations at different development stages. Although chro-
matin associated RNAs (CARs) were recently sequenced on a
genome wide scale, the exact region of their association with
chromatin has not been investigated [104]. The identiﬁcation
of the region of chromatin interaction is essential for the
discovery of targets since ncRNAs do not always associate
with genomic regions of sequence homology. Gene expression
analysis using high throughput quantitative techniques such
as CAGE [105] conducted in parallel will identify ncRNA chro-
matin interactions resulting in activation or repression of
genes. Thus new candidate ncRNAs likely to create silencing
domains or participate in the activation of genes can be
identiﬁed and individually investigated.
Itis also necessarytoidentify the distalenhancers of genes
regulated by ncRNAs. Although some recent studies have
identiﬁed enhancers in neurons [78] and cardiomyocytes
[83], since enhancers are tissue and development stage
speciﬁc, there is a need to perform ChIP sequencing using
antibodies against speciﬁc markers such as P300, H3K4me1,
H3K27ac and histone variant H2A.Z in various tissues to
identify tissue speciﬁc enhancers on a global scale. In
addition, technologies such as HiC and ChIA-PET, which
can identify genome wide chromatin-chromatin associations,
have the capability to identify distal enhancers in physical
contact with promoters [106, 107]. The HiC technique is based
on proximity ligation and provides unbiased genome-wide
maps of chromatin-chromatin association [106]. The CHIA-
PET technique, based on immunoprecipitation, proximity
ligation and paired end tag sequencing [107] will be especially
useful in the identiﬁcation of enhancers, if performed with
antibodies against P300, H3K4me1 and H3K27ac.
It is also important to catalogue lncRNAs and permit their
search on public genome browsers. Although some lncRNAs are
viewable on public genome browsers and lncRNAdb, thousands
of human lncRNAs and expressed retrotransposons identiﬁed in
FANTOM3 [1, 90], lincRNAs identiﬁed in other projects using the
k4-36 signature[108]andlaterwith theRIP-seqassay[26]arenot
clearly annotated on the public browsers.
Thus we remain unaware of the regulatory lncRNAs expressed
from the genomic vicinity of our genes of interest. Given the
role of lncRNAs in gene regulation, the availability of dedi-
cated tracks of full-length lncRNAs derived from FANTOM3,
FANTOM5, ENCODE [1, 109, 110] and other similar projects
would be of immense beneﬁt to biologists seeking answers to
gene regulation. Since most regulatory lncRNAs are likely to
be nuclear, as major transcriptome sequencing projects such
as ENCODE and FANTOM5 progress, additional tracks in pub-
lic browsers based on the distribution of these lncRNAs such
as nuclear, cytoplasmic, nucleoplasm or chromatin associated
etc will speed up experimental validation of lncRNA related
hypotheses.
Conclusions and perspectives
The common themes in the mechanism of silencing
mediated by lncRNAs, such as Xist, HOTAIR, Kcnq1ot1
and Airn, have provided a sound template for the
investigation of other similar molecules in cells, whose
function remains unknown. Although in this review
we have focused on the silencing aspect of lncRNA function,
evidence is now emerging of lncRNAs participating in
gene activation during chromatin looping [111]. Furthermore,
novel gene speciﬁc mechanisms of silencing are also being
uncovered [50].
Thus, it is clear that much remains to be learned in
the ﬁeld of lncRNA function. In addition, another layer of
regulation appears to exist at the cellular level, which
dictates the transcriptional program, by specifying lncRNA
targets. This regulatory layer appears to be tissue and
development stage speciﬁc and concerted efforts are
needed to decipher this next level of control. Just as the
lncRNAs have similarities in their modes of action, it is likely
that the additional layer of regulatory control over lncRNA
mediated silencing may also have common mechanisms.
Whether distal enhancers, ncRNAs or other protein com-
plexes exercise this control remains to be investigated. In
the near future we may unravel universal techniques to
reverse or enforce epigenetic silencing of speciﬁc targets
mediated by lncRNAs, providing novel therapeutic avenues
for some disorders.
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